Skip to main content

Efforts to protect innovations through India IPR policy have received a leg up, but the rejection of a compulsory licence application proves the real icing on the cake.

The government’s commitment to the global community at large to protect innovations is now visible through India’s national IPR policy, Make in India and the recent success stories in the Merck and Hoffman La Roche patent infringement actions. The icing on the cake was the recent rejection of the compulsory license application of Lee Pharma, a Hyderabad-based generic company, for AstraZeneca’s patent for saxagliptin. Since 2011, three applications have filed under Section 84 of the Indian Patents Act. While the Controller General granted a compulsory license to Natco for Bayer’s patent for Nexavar, BDR Pharmaceuticals’ and Lee Pharmaceuticals’ applications for compulsory license for patent claims on dasatinib (Bristol-Myers Squibb) and saxagliptin (AstraZeneca) were prima facie rejected in 2014 and 2015-2016.

This article walks through the compulsory license proceedings of Lee Pharma for saxagliptin. 

Authored by Pravin Anand and Archana Shanker.

This article was published in Asia IP February 2016.

Read more

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Nov 18, 2026

A few seconds of weather footage broadcast in New Delhi ended up at the center of a federal copyright lawsuit in California. A news broadcaster based in

Can Foreign Copyright Owners Sue Indian Broadcasters Abroad? The Territorial Reach of Copyright Disputes
News & Updates, Thought Leadership
•
Nov 14, 2026

Generative artificial intelligence systems are trained on large volumes of information, including text, images, news articles and other digital material.

Can AI Training be Copyright Infringement? The ANI v. OpenAI Dispute in India
News & Updates, Thought Leadership
•
Nov 11, 2026

Think about the apps you use every day. Their visual identity is often the first thing you recognise: the arrangement of icons, navigation menus, buttons,

Can You Patent the Look of an App? GUI and Icon Protection in India
News & Updates, Thought Leadership
•
Nov 09, 2026

‘First published on Chambers’ By: Dhruv Anand, Dhananjay Khanna and Bhavya Verma It will not be an exaggeration to say that there has been an explosion

PERSONALITY RIGHTS – CURRENT TRENDS